Donor surfactant protein A2 polymorphism and lung transplant survival

Abstract

Donor lung SP-A gene polymorphisms are associated with post-transplant clinical outcome. Lungs from donors with the SP-A2 variant 1A¹ had a reduced survival at 1 year. The observed donor genetic differences, <i>via</i> innate immunity relate to the post-transplant clinical outcome.